日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O6:K15:H31 Sec-independent protein translocase protein TatB (tatB), partial CSB-YP610625EGY
CSB-EP610625EGY
CSB-BP610625EGY
CSB-MP610625EGY
CSB-EP610625EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Putative ECA polymerase (wzyE), partial CSB-YP610626EGY
CSB-EP610626EGY
CSB-BP610626EGY
CSB-MP610626EGY
CSB-EP610626EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Low affinity potassium transport system protein kup (kup), partial CSB-YP610627EGY
CSB-EP610627EGY
CSB-BP610627EGY
CSB-MP610627EGY
CSB-EP610627EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 ATP synthase subunit a (atpB), partial CSB-YP610628EGY1
CSB-EP610628EGY1
CSB-BP610628EGY1
CSB-MP610628EGY1
CSB-EP610628EGY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Multidrug resistance protein MdtL (mdtL), partial CSB-YP610629EGY
CSB-EP610629EGY
CSB-BP610629EGY
CSB-MP610629EGY
CSB-EP610629EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Protein CbrA (cbrA) CSB-YP610630EGY
CSB-EP610630EGY
CSB-BP610630EGY
CSB-MP610630EGY
CSB-EP610630EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Uncharacterized protein yicS (yicS) CSB-YP610631EGY
CSB-EP610631EGY
CSB-BP610631EGY
CSB-MP610631EGY
CSB-EP610631EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Orotate phosphoribosyltransferase (pyrE) CSB-YP610632EGY
CSB-EP610632EGY
CSB-BP610632EGY
CSB-MP610632EGY
CSB-EP610632EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 ADP-L-glycero-D-manno-heptose-6-epimerase (hldD) CSB-YP610633EGY
CSB-EP610633EGY
CSB-BP610633EGY
CSB-MP610633EGY
CSB-EP610633EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 2,3-diketo-L-gulonate reductase (dlgD) CSB-YP610634EGY
CSB-EP610634EGY
CSB-BP610634EGY
CSB-MP610634EGY
CSB-EP610634EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Glycine--tRNA ligase beta subunit (glyS) CSB-YP610635EGY
CSB-EP610635EGY
CSB-BP610635EGY
CSB-MP610635EGY
CSB-EP610635EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Nickel import ATP-binding protein NikE (nikE) CSB-YP610636EGY
CSB-EP610636EGY
CSB-BP610636EGY
CSB-MP610636EGY
CSB-EP610636EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP610637EGY
CSB-EP610637EGY
CSB-BP610637EGY
CSB-MP610637EGY
CSB-EP610637EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Ferrous iron transport protein C (feoC) CSB-YP610638EGY
CSB-EP610638EGY
CSB-BP610638EGY
CSB-MP610638EGY
CSB-EP610638EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Protein TusC (tusC) CSB-YP610639EGY
CSB-EP610639EGY
CSB-BP610639EGY
CSB-MP610639EGY
CSB-EP610639EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 50S ribosomal protein L3 (rplC) CSB-YP610640EGY
CSB-EP610640EGY
CSB-BP610640EGY
CSB-MP610640EGY
CSB-EP610640EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 30S ribosomal protein S17 (rpsQ) CSB-YP610641EGY
CSB-EP610641EGY
CSB-BP610641EGY
CSB-MP610641EGY
CSB-EP610641EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 30S ribosomal protein S5 (rpsE) CSB-YP610642EGY
CSB-EP610642EGY
CSB-BP610642EGY
CSB-MP610642EGY
CSB-EP610642EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 30S ribosomal protein S13 (rpsM) CSB-YP610643EGY
CSB-EP610643EGY
CSB-BP610643EGY
CSB-MP610643EGY
CSB-EP610643EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O6:K15:H31 Ribosomal RNA small subunit methyltransferase B (rsmB) CSB-YP610644EGY
CSB-EP610644EGY
CSB-BP610644EGY
CSB-MP610644EGY
CSB-EP610644EGY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×